117 related articles for article (PubMed ID: 9479830)
1. Small-molecule inhibitors of cyclin-dependent kinases: molecular tools and potential therapeutics.
Walker DH
Curr Top Microbiol Immunol; 1998; 227():149-65. PubMed ID: 9479830
[No Abstract] [Full Text] [Related]
2. Chemical inhibitors of cyclin-dependent kinases.
Meijer L; Kim SH
Methods Enzymol; 1997; 283():113-28. PubMed ID: 9251015
[No Abstract] [Full Text] [Related]
3. Cinnamaldehydes inhibit cyclin dependent kinase 4/cyclin D1.
Jeong HW; Kim MR; Son KH; Han MY; Ha JH; Garnier M; Meijer L; Kwon BM
Bioorg Med Chem Lett; 2000 Aug; 10(16):1819-22. PubMed ID: 10969976
[TBL] [Abstract][Full Text] [Related]
4. Imidazo[1,2-a]pyridines: a potent and selective class of cyclin-dependent kinase inhibitors identified through structure-based hybridisation.
Anderson M; Beattie JF; Breault GA; Breed J; Byth KF; Culshaw JD; Ellston RP; Green S; Minshull CA; Norman RA; Pauptit RA; Stanway J; Thomas AP; Jewsbury PJ
Bioorg Med Chem Lett; 2003 Sep; 13(18):3021-6. PubMed ID: 12941325
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent kinase inhibitors.
Fischer PM; Endicott J; Meijer L
Prog Cell Cycle Res; 2003; 5():235-48. PubMed ID: 14593718
[TBL] [Abstract][Full Text] [Related]
6. Imidazo[1,2-a]pyridines. Part 2: SAR and optimisation of a potent and selective class of cyclin-dependent kinase inhibitors.
Byth KF; Culshaw JD; Green S; Oakes SE; Thomas AP
Bioorg Med Chem Lett; 2004 May; 14(9):2245-8. PubMed ID: 15081017
[TBL] [Abstract][Full Text] [Related]
7. The effect of desolvation on the binding of inhibitors to HIV-1 protease and cyclin-dependent kinases: Causes of resistance.
Fong CW
Bioorg Med Chem Lett; 2016 Aug; 26(15):3705-13. PubMed ID: 27317642
[TBL] [Abstract][Full Text] [Related]
8. Identification of selective inhibitors of cyclin dependent kinase 4.
Carini DJ; Kaltenbach RF; Liu J; Benfield PA; Boylan J; Boisclair M; Brizuela L; Burton CR; Cox S; Grafstrom R; Harrison BA; Harrison K; Akamike E; Markwalder JA; Nakano Y; Seitz SP; Sharp DM; Trainor GL; Sielecki TM
Bioorg Med Chem Lett; 2001 Aug; 11(16):2209-11. PubMed ID: 11514172
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of the cell cycle--involvement of protein inhibitors of cyclin-dependent kinases].
Grzelakowska-Sztabert B
Postepy Biochem; 1995; 41(2):80-93. PubMed ID: 7479444
[No Abstract] [Full Text] [Related]
10. Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors.
Nugiel DA; Etzkorn AM; Vidwans A; Benfield PA; Boisclair M; Burton CR; Cox S; Czerniak PM; Doleniak D; Seitz SP
J Med Chem; 2001 Apr; 44(9):1334-6. PubMed ID: 11311054
[No Abstract] [Full Text] [Related]
11. Small-molecule inhibitors of the cell cycle.
Crews CM; Mohan R
Curr Opin Chem Biol; 2000 Feb; 4(1):47-53. PubMed ID: 10679374
[TBL] [Abstract][Full Text] [Related]
12. Aminoimidazo[1,2-a]pyridines as a new structural class of cyclin-dependent kinase inhibitors. Part 1: Design, synthesis, and biological evaluation.
Jaramillo C; de Diego JE; Hamdouchi C; Collins E; Keyser H; Sánchez-Martínez C; del Prado M; Norman B; Brooks HB; Watkins SA; Spencer CD; Dempsey JA; Anderson BD; Campbell RM; Leggett T; Patel B; Schultz RM; Espinosa J; Vieth M; Zhang F; Timm DE
Bioorg Med Chem Lett; 2004 Dec; 14(24):6095-9. PubMed ID: 15546737
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of C2 alkynylated purines, a new family of potent inhibitors of cyclin-dependent kinases.
Legraverend M; Ludwig O; Bisagni E; Leclerc S; Meijer L
Bioorg Med Chem Lett; 1998 Apr; 8(7):793-8. PubMed ID: 9871543
[TBL] [Abstract][Full Text] [Related]
14. Cyclin-dependent kinase inhibitors: useful targets in cell cycle regulation.
Sielecki TM; Boylan JF; Benfield PA; Trainor GL
J Med Chem; 2000 Jan; 43(1):1-18. PubMed ID: 10633033
[No Abstract] [Full Text] [Related]
15. Imidazo[1,2-b]pyridazines: a potent and selective class of cyclin-dependent kinase inhibitors.
Byth KF; Cooper N; Culshaw JD; Heaton DW; Oakes SE; Minshull CA; Norman RA; Pauptit RA; Tucker JA; Breed J; Pannifer A; Rowsell S; Stanway JJ; Valentine AL; Thomas AP
Bioorg Med Chem Lett; 2004 May; 14(9):2249-52. PubMed ID: 15081018
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological activity of 2-anilino-4-(1H-pyrrol-3-yl) pyrimidine CDK inhibitors.
Wang S; Wood G; Meades C; Griffiths G; Midgley C; McNae I; McInnes C; Anderson S; Jackson W; Mezna M; Yuill R; Walkinshaw M; Fischer PM
Bioorg Med Chem Lett; 2004 Aug; 14(16):4237-40. PubMed ID: 15261277
[TBL] [Abstract][Full Text] [Related]
17. Imidazole piperazines: SAR and development of a potent class of cyclin-dependent kinase inhibitors with a novel binding mode.
Finlay MR; Acton DG; Andrews DM; Barker AJ; Dennis M; Fisher E; Graham MA; Green CP; Heaton DW; Karoutchi G; Loddick SA; Morgentin R; Roberts A; Tucker JA; Weir HM
Bioorg Med Chem Lett; 2008 Aug; 18(15):4442-6. PubMed ID: 18617397
[TBL] [Abstract][Full Text] [Related]
18. Designing inhibitors of cyclin-dependent kinases.
Hardcastle IR; Golding BT; Griffin RJ
Annu Rev Pharmacol Toxicol; 2002; 42():325-48. PubMed ID: 11807175
[TBL] [Abstract][Full Text] [Related]
19. Discovery and initial characterization of the paullones, a novel class of small-molecule inhibitors of cyclin-dependent kinases.
Zaharevitz DW; Gussio R; Leost M; Senderowicz AM; Lahusen T; Kunick C; Meijer L; Sausville EA
Cancer Res; 1999 Jun; 59(11):2566-9. PubMed ID: 10363974
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase inhibitors from the urea class.
Dumas J
Curr Opin Drug Discov Devel; 2002 Sep; 5(5):718-27. PubMed ID: 12630292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
